Androgen receptor protein expression in prostatic tissues in Black and Caucasian men

Prostate

Volumn 59, Issue 4, 2004, Pages 460-468

  Olapade Olaopa, E Oluwabunmi ^a,b,e   Muronda, Charles A ^c   MacKay, E Hugh ^a   Danso, Alex P ^c   Sandhu, Davinder P ^a   Terry, Timothy R ^a   Habib, Fouad K ^d  

^a LEICESTER GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF IBADAN   (Nigeria)

^c African Institute of Urology   (Zimbabwe)

^d WESTERN GENERAL HOSPITAL   (United Kingdom)

^e UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

Androgen receptor; Black; BPH; Caucasian; Prostate cancer; Stromal epithelial interaction

Indexed keywords

ANDROGEN RECEPTOR;

ARTICLE; CAUCASIAN; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; HYPOTHESIS; IMMUNOHISTOCHEMISTRY; MALE; NEGRO; PHENOTYPE; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; PROSTATE EPITHELIUM; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

AFRICAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; MALE; PROSTATE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN;

EID: 2542476129     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/pros.20014     Document Type: Article

References (39)

1. D'Aunoy R, Schenken J, Burns E. The relative incidence of hyperplasia of the prostate in the White and coloured races in Louisiana. South Med J 1939;32:47-52.
2. Morrison A. Risk factors for surgery for prostatic hypertrophy. Am J Epidemiol 1994;139:114-115.
3. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun M. Cancer statistics 2003. CA Cancer J Clin 2003;53:5.
4. Glover F, Coffey D, Douglas L, Cadogan M, Russell H, Tulloch T, Baker T, Wan R, Walsh P. The epidemiology of prostate cancer in Jamaica. J Urol 1998;159:1984-1987.
5. Ogunbiyi J, Shittu O. Increased incidence of prostate cancer in Nigerians. J Nat Med Assoc 1999;91:159-164.
6. Ries L, Eisner M, Kosary C, Hankey B, Miller B, Clegg L. SEER cancer statistics review 1973-1997. Bethesda, Maryland: National Cancer Institute;2000.
7. Moul J, Sesterhenn I, Connelly R, Douglas T, Srivastava S, Mostofi F, McLeod D. Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men. JAMA 1995;274:1277-1281.
8. Powell I, Banerjee M, Sakr W, Grignon D, Wood DP Jr, Novallo M, Pontes E. Should African-American men be tested for prostate carcinoma at an earlier age than White men? Cancer 1999;85:472-477.
9. Thompson I, Tangen C, Toclher A, Crawford E, Eisenberger M, Moinpour C. Association of African-American ethnic background with survival in men with metastatic prostate cancer. J Nat Cancer Inst 2001;93:219-225.
10. Chung L, Zhau H. The role of sromal-epithelial interaction in the normal and abnormal growth of the prostate. In: Schalken J, editor. Basic research in urological oncology. Basel: Karger; 1996. pp 16-27.
11. Bruchovsky N, Snoek R, Rennie P, Akakura K, Goldenberg L, Cleave M. Control of tumor progression by maintenance of apoptosis. Prostate (Suppl) 1996;6:13-21.
12. Ross R, Bernstein L, Judd H, Hamish R, Pike M, Henderson B. Serum testosterone in healthy Black and White men. J Nat Cancer Inst 1986;76:45-48.
13. Ellis L, Nyorg H. Racial/ethnic variations in male testosterone levels: A probable contributor to group differences in health. Steroids 1992;57:72.
14. Ross R, Bernstein L, Lobo R, Shimuzu H, Stancyzk F, Pike M, Henderson B. 5 alpha-reductase activity and risk of prostate cancer among Japanese and US White and Black males. Lancet 1992;339:887-889.
15. Makridakis N, Ross R, Pike M, Crocitto L, Kolonel L, Pearce C, Hendersen B, Reichardt J. Association of mis-sense association in SRD5A2 gene with prostate cancer in African-American and Hispanic Men in Los Angeles, USA. Lancet 1999;354:975-978.
16. Edwards A, Hammond H, Jin L, Laskey C, Chakraborty R. Genetic variation at five trimeric and terameric tandem repeat loci in four human populations. Genomics 1992;12:241-253.
17. Irvine R, Yu M, Ross R, Coetzee G. The CAG and GGC microsatellites of the androgen receptor gene are in linkage dis-equilibrium in men with prostate cancer. Cancer Res 1995;55: 1620-1623.
18. Leav I, McNeal J, Kwan P, Komminoth P, Merk F. Androgen receptor expression in prostatic dysplasia (prostatic intraepithelial neoplasia) in the human prostate: An immunohistochemical and in situ hybridization study. Prostate 1996;29:137-145.
19. Harper M, Glynne-Jones E, Goddard L, Mathews P, Nicholson R. Expression of androgen receptor and growth factors in premalignant lesions of the prostate. J Clin Pathol 1998;186:169-177.
20. Olapade-Olaopa E, Horsburgh T, MacKay E, Sandhu D, Terry T, Moscatello D, Wong A, Habib F. Evidence for the differential expression of a variant EGF receptor in human prostate cancer. Br J Cancer 2000;82:186-194.
21. Ford O, Gregory C, Kim D, Smitherman A, Mohler J. Androgen receptor gene amplification and protein expression in recurrent prostate cancer. J Urol 2003;170:1817-1821.
22. Koivisto P, Kolmer M, Visakorpi T, Kallioniemi O. Androgen receptor gene and hormonal therapy failure of prostate cancer. Am J Pathol 1998;152:
23. Gleason D, Mellinger G, Prediction of prognosis for prostate adenocarcinoma by combined histological grading and clinical staging. J Urol 1974;111:58-64.
24. Olapade-Olaopa E, Ogunbiyi J, MacKay E, Muronda C, Alonge T, Danso A, Moscatello D, Sandhu D, Shittu O, Terry T, Wong A, Habib F. Further characterisation of storage-related alterations in immunoreactivity of archival tissue sections and its implications for collaborative multicentre immunohistochemical studies. Appl Immunohistochem Molecul Morphol 2001;9:180-186.
25. Olapade-Olaopa E, MacKay E, Taub N, Sandhu D, Terry T, Habib F. Malignant transformation of human prostatic epithelium is associated with the loss of androgen receptor immuno-reactivity in surrounding stroma. Clin Cancer Res 1999;5:569-576.
26. Henshall S, Quinn D, Lee C, Head D, Golovsky D, Brenner P, Delprado W, Stricker P, Grygiel J, Sutherland R. Altered expression of androgen receptor in the malignant epithelium and adjacent stroma is associated with early relapse in prostate cancer. Cancer Res 2001;61:423-437.
27. Masai M, Sumiya H, Akimoto S, Yatani R, Chang C, Liao S, Shimazaki J. Immunohistochemical study of androgen receptor in benign hyperplastic and cancerous human prostates. Prostate 1990;17:293-300.
28. Chodak G, Kranc D, Puy L, Takeda H, Johnson K, Chang C. Nuclear localisation of androgen receptor in heterogeneous samples of normal, hyperplastic and neoplsatic human prostate. J Urol 1992;147:796-803.
29. Habib F, S O, Busutil A, Chisolm G. Androgen receptors in cancer of the prostate: Correlation with the stage and grade of the tumour on receptor content. Cancer 1986;57:2351-2356.
30. Linja M, Savinainen K, Saramaki O, Tammela T, Vessella R, T V. Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancer. Cancer Res 2001;61:3550-3555.
31. Gaston K, Kim D, Singh S, Ford O, Mohler J. Racial differences in androgen receptor protein expression in men with clinically localized prostate cancer. J Urol 2003;170:990-993.
32. Grayhack J, McVary K, Kozlowski J. Adult and pediatric urologyVol. 2, 4th edn. Philadelphia: Lippincott Williams & Wilkins;2002: p 1410-1412.
33. Osegbe D, Ogunlewe J. Androgen concentration in Blacks with benign and malignant prostatic disease. J Urol 1988;140:160-164.
34. Habib F, Goodman C, Buck C. Androgen concentration in expressed prostatic secretions: No correlation with tissue levels. Urol Res 1992;20:281-284.
35. Zhou Z, Lane M, Kemppainen J, French F, Wilson E. Specificity of ligand-dependent androgen receptor stabilization: Receptor domain interactions influence ligand dissociation and receptor stability. Mol Endocrinol 1995;9:208.
36. Chung L, Zhau H. Stromal-epithelial interaction: From bench to bedside. In: Chung LWK, Isaacs WB, Simons JW, editors. Prostate cancer: biology, genetics and the new therapeutics. Totawa, New Jersey: Humana Press;2001. pp 341-362.
37. Hall J, Maitland N, Stower M, Lang S. Primary prostate stromal cells modulate the morphology and migration of primary prostate epithelial cells in Type 1 collagen gels. Cancer Res 2002;62:58-62.
38. Haggman M, Macoska J, Wonjo K, Oesterling J. The relationship between prostatic intraepithelial neoplasia and prostate cancer. J Urol 1997;158:12-22.
39. Athanose B. Age and race distribution of high grade intraepithelial neoplasia (HGPIN): An autopsy study in Brazil (South America). Mod Pathol 1996;9:71A.